DIFFERENT STAKEHOLDER PERSPECTIVES ON PHARMACOGENOMIC TESTING

被引：0
|
作者：
Patel, H. [1 ]
Ursan, I [1 ]
Zueger, P. [1 ]
Pickard, A. S. [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1241
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A244 / A244
页数：1
相关论文
共 50 条
  • [31] The challenges of implementing pharmacogenomic testing in the clinic
    Moyer, Ann M.
    Caraballo, Pedro J.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (06) : 567 - 577
  • [32] Pharmacogenomic Testing to Select Antiplatelet Therapy
    Price, Matthew J.
    Angiolillo, Dominick J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (17) : 1878 - 1881
  • [33] Insurance coverage for pharmacogenomic testing in the USA
    Williams, Marc S.
    PERSONALIZED MEDICINE, 2007, 4 (04) : 479 - 487
  • [34] Review and consensus on pharmacogenomic testing in psychiatry
    Faiz, Mark
    Ahmed, Sanjida
    PSYCHOLOGICAL MEDICINE, 2024, 54 (15) : 4456 - 4456
  • [35] A brighter future for the implementation of pharmacogenomic testing
    van der Wouden, Cathelijne H.
    Swen, Jesse J.
    Samwald, Matthias
    Mitropoulou, Christina
    Schwab, Matthias
    Guchelaar, Henk-Jan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2016, 24 (12) : 1658 - 1660
  • [36] Direct-to-consumer pharmacogenomic testing
    Howard, Heidi Carmen
    Borry, Pascal
    PHARMACOGENOMICS, 2011, 12 (10) : 1367 - 1370
  • [37] A brighter future for the implementation of pharmacogenomic testing
    Cathelijne H van der Wouden
    Jesse J Swen
    Matthias Samwald
    Christina Mitropoulou
    Matthias Schwab
    Henk-Jan Guchelaar
    European Journal of Human Genetics, 2016, 24 : 1658 - 1660
  • [38] Clinical pharmacogenomics: patient perspectives of pharmacogenomic testing and the incidence of actionable test results in a chronic disease cohort
    Mukherjee, Chandrama
    Sweet, Kevin M.
    Luzum, Jasmine A.
    Abdel-Rasoul, Mahmoud
    Christman, Michael F.
    Kitzmiller, Joseph P.
    PERSONALIZED MEDICINE, 2017, 14 (05) : 383 - 388
  • [39] Warfarin and pharmacogenomic testing: The case for restraint
    Garcia, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) : 303 - 305
  • [40] Preemptive Pharmacogenomic Testing in the Psychiatric Clinic
    Patrinosa, G. P.
    Skokou, M.
    Karaivazoglou, K.
    Ferentinos, P.
    Kalogeropoulou, M.
    Kolios, P.
    Gerasimou, H.
    Bali, P.
    Mitropoulos, K.
    Pagiati, S.
    Douzenis, A.
    Gourzis, F.
    Asimakopoulos, K.
    Tsermpini, E. E.
    PUBLIC HEALTH GENOMICS, 2018, 21 : 2 - 2
12345